Company / Income Tax per Share
Arrowhead Pharmaceuticals Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.17
FY2025
5-year range
-$0.03 / $0.17
FY2021-FY2025
Trend
+767.9%
vs FY2024
Sector context
#40 of 201
Health Care
What the data says
Income Tax per Share changed +768% YoY in FY2025, a notable deviation from the 9-year average annual change of -15112%.
Based on SEC 10-K filings.
0.17 in FY2025 with a 5-year CAGR of +506.8%. Top quartile in the Health Care sector.
Increased from $0.00 to $0.17 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +506.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 201This company $0.17 Sector average $1.35
▼
-87.2% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 767.9% year-over-year.
- Ranks #40 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.17 | +767.9% |
| FY2024 | -$0.03 | -136707.0% |
| FY2023 | $0.00 | -1.5% |
| FY2022 | $0.00 | -1.9% |
| FY2021 | $0.00 | -6.7% |
| FY2020 | $0.00 | -22.8% |
| FY2019 | $0.00 | -15.5% |
| FY2018 | $0.00 | -6.7% |
| FY2017 | $0.00 | -14.6% |
| FY2016 | $0.00 | -58.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026